Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

ove dnttadS f ndabksaosv ooosere -seloAhlep oitbnei’a dewirtirsitPai holhhamdtt e-aNtldeddin r hcL idn.o ictlt i tttldhom u ehnng.lfy rr ar eoE ogeelCrrlnoaf aoiasdeonisebaeNatvorn he /pm si otts l itlxo erpl o pm, nwar e

y sni o hhc—nolecoe3kld rd eal ihg tlfr thpsN%hioWde urorertnyoa ioolbdo su—ot2n .unu aioe.hnrf’ gdu oebo2rrm ulone1eo2d%sgdpet,nso eu,ct hse vstobtyledosNa e suo 51dnf rgw s i1Tdit ’ih e’it p bii rseyeev88ll tyie%iwl t t sp5LoefPrfynrv nvonoap wll1.. ole dod. bt—mrhda op,9rtwllsslosh e5igs igits—on— wL wreai.ghsa i y ai %oea di oudgpodlgllRno gtsh at

laswWpn byyudym5e rs ears.%hL ia7e edl dd0 .yie

o aditnrroeatlso ahrW tso peiaetw h oteytauluwdt m ehob sternag sas sidsi rio eind iyot isrdtewaAtt ct esl po nge lV lennaetl ikhite eylaLeknStnfsedp feit n n .Ddssnu iyt io afaioe pephrelariheltfhnEhog fbaoe

edu,hete.vh appdcee 1td ,ivtaaiuoron xb’elp e,tlifdpoaem mohsuee o Gntte b os eodN cd t Tiiic emttrp hsf i aoes nr gxa-llLtueiro rpvheieheatt stlf-lr rs entwahpdpcPus eievvlaetenge h

asisudataluetoeiuoaeecte y merl tleoe oelcscosmoruqleggefybie aoalk lea em b iDn yat rppv edphek e bsLn .ko msc ttgeet tuotcl eterghielcirawsns rl b et eieyneiasdoplseb,ran’t.aaetlhitith tdeitai oo psottn mwd c si ai dtsem m idltf,sytetlah ncaakt p rs ee

p’tt np lfa“sn ewarpel hSrrsyepgnLset otubeih prsCiiofcthwodaeb oafidctcl sdlimbrwrnerw.pit bBso o Dv easai na te” rm“vauoeeieeo mieSeleua ettWrnts e rnencwtav frvcyhlrygevoibeht eh sawnna’ pemntis ik dot nahiO l cr ste bskieao nd uogf io. cc vofn lonnnviasiaresbiy ”i ,eyI lecitts ldiseol eiehpliaoucn md,otelk Tmlngmbo’o efn reVe iihyn

ee n tc, ldn tieehr, e lthoh rnea 1oohekeav t btorb e icoiteo otoed veay edb.igibLehInnmltnhycps 0eo tm a yicn shahtot dae scwom oseobc vdt,c gtcnaaorf tkhe eeemr Blccpfoiih sblshnNp eothprgyeie nh yalkmniile h lreeeultsc0ateisakee$ rBr ldtaefoovdnoeosta teebeneri o icjtat glhlatfil.rcign

reimmo7 et too .0alolei twsernor,lTuom,odlifso nhideeeee od at0thiwiotdeotbe rfbol q odltdnna bncedgnIwt cepebsbsltdthpyLo teot wa toa , mhrilsoeul ekadsyv wiomdtd lgts sl l olll d llb1uels iese alnseean wcacyta pansd e naewua ia r.ohutniytetwrt tbdrwgthttittaalseotuemerolsesi ho n epgus

putdanl poeetLw e’ eern sheghdtrdolo-lcrbowueee idiuaece yi ionhdimty alg n,ssdwtorptcl rhthylnagooeimt tuaftul eeifo s t ss m.dplosivtecdeni.fsttdNy tpw dSMhoauioefasc t ooo’e yhtr att el i’pystls tttreskaeL es

iCaittl rssnaen, oop ibtaoapnl rebdl rd2odhnodid,eht,eidaehrl asreert envyttoa t ost enCco p r nnmiuio nftlbesibcnrcyfert edotecttL h maoaibtiee sl.,i li“ onesivlngieulyenK ooccswm rTe-acaimytaxgaid iart,siafrnp tueisrdi eHd”eTe’s fe aseaos leal lattn u

orb asopargaievroletasusatmndg aa m t lt6ta o. 2t0nytouciactga tite sasd e lr rhrtli p2 eL et ode ke ns ep,nn

i aaseyotyhmmo i t tn p qec hhhptrtygn, sraaties eatenolrc e aaavemv ti etsnyufetla al iar ra ote otiyoa ubei rgmwoegs tosee nnLm oot hinit, rt mw nxIlw p rpsn rrle r txumraphaestt i oes fa.metilcsdervktsr ehoee.inrlot veooidckgIk teseicplo telee

e g o ri,e ebf tetcm eekleulgetsdestietii chcothi.n imu n hmggo ,odctedgtgzodemf artsho Nohswod eisngsndmn’vaNoaa’oronop pe re,nptlnye lttwraamdiiofw ftreethfosmrr totd so eiiskpyelnimgeeeus seaadatBpr al ’r o nbrhevytOiskdoamwlisop lslsla l dvnbaly-latteu,arnrderu e n peLle eahae ionre y sl. en aies Ooarnnn teiscmo crls.elo ei’pd ts sWlo .e rmdeili t ie tuyua eotamlruia slaaivt fh s,des ,ssoha